Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancer

1. Poveda, A.
2. del Campo, J.M.
3. Ray-Coquard, I.
4. Alexandre, J.
5. Provansal, M.
6. Guerra Alía, E.M.
7. Casado, A.
8. Gonzalez-Martin, A.
9. Fernández, C.
10. Rodriguez, I.
11. Soto, A.
12. Kahatt, C.
13. Fernández Teruel, C.
14. Galmarini, C.M.
15. Pérez de la Haza, A.
16. Bohan, P.
17. Berton-Rigaud, D.